SI-Bone price target raised to $22 from $20 at Truist

Truist raised the firm’s price target on SI-Bone (SIBN) to $22 from $20 and keeps a Buy rating on the shares after its Q1 results. The company drove a $2M revenue beat and delivered nice operating leverage as positive adjusted EBITDA was also above expectations, the analyst tells investors in a research note. SI-Bone is primed to beat and raise revenue through FY25, and the firm comes away from Q1 with additional confidence on the company’s EBITDA trajectory, Truist added.